Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Gelfand

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Archives of Internal Medicine|November 1, 1979
Bacteremia in the hemodialyzed patient. A persistent problem in spite of technological progressM C Gelfand
Journal of Dialysis|January 1, 1979
Hemoperfusion: present and futureM C Gelfand
Contributions to Nephrology|January 1, 1982
Hemoperfusion in toxic ingestions and hepatic encephalopathy: have the expectations been achieved?M C Gelfand
JAMA|December 15, 1978
Hemoperfusion in drug overdoseM C Gelfand
Medical Hypotheses|September 1, 1989
Polycystic kidneys do maintain good endocrine functionC Rotellar, M C Gelfand
The International Journal of Artificial Organs|March 1, 1981
Iron overload in patients on maintenance hemodialysisH Bregman, M C Gelfand
Transplantation|November 1, 1970
Prognosis of renal allotransplants in patients with bilateral renal cortical necrosisM C Gelfand, E A Friedman
Clinical Toxicology|November 1, 1980
Hemoperfusion in drug overdosage: a technique when conservative management is not sufficientM C Gelfand, J F Winchester
Cellular Immunology|March 30, 1974
Cooperation of three lymphoid cells in allograft rejectionM C Gelfand, A D Steinberg
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cellsM C Gelfand, W E Paul
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Archives of Internal Medicine|November 1, 1979
Bacteremia in the hemodialyzed patient. A persistent problem in spite of technological progressM C Gelfand
Journal of Dialysis|January 1, 1979
Hemoperfusion: present and futureM C Gelfand
Contributions to Nephrology|January 1, 1982
Hemoperfusion in toxic ingestions and hepatic encephalopathy: have the expectations been achieved?M C Gelfand
JAMA|December 15, 1978
Hemoperfusion in drug overdoseM C Gelfand
Medical Hypotheses|September 1, 1989
Polycystic kidneys do maintain good endocrine functionC Rotellar, M C Gelfand
The International Journal of Artificial Organs|March 1, 1981
Iron overload in patients on maintenance hemodialysisH Bregman, M C Gelfand
Transplantation|November 1, 1970
Prognosis of renal allotransplants in patients with bilateral renal cortical necrosisM C Gelfand, E A Friedman
Clinical Toxicology|November 1, 1980
Hemoperfusion in drug overdosage: a technique when conservative management is not sufficientM C Gelfand, J F Winchester
Cellular Immunology|March 30, 1974
Cooperation of three lymphoid cells in allograft rejectionM C Gelfand, A D Steinberg
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cellsM C Gelfand, W E Paul
Pageof 8